CSI Market
Sign In | Register

Immunitybio inc (IBRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IBRX Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Immunitybio inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent75.67
Marketable Securities, Current SH281.70
Cash & Short-term Investments356.00
Accounts receivable53.47
Other Receivables, Net, Current0.00
Inventories1.94
Other Current Assets24.92
Prepaid Expense And Other Assets Current0.00
Total Current Assets438.98
Equipment/Property/Plant Net114.22
Intangible Assets11.84
Long-term investments1.28
Other Assets, Noncurrent62.19
Operating Lease Right Of Use Asset33.03
Total Assets628.50
Liabilities
Accounts Payable, Current AC55.67
Financial Instruments23.70
Other Liabilities, Current0.00
Discontinued Operation, Liabilities0.02
Total Current Liabilities76.73
Long-term debt415.09
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt415.09
Other liabilities, Noncurrent1,182.45
OperatingLeaseLiabilityNoncurrent33.15
Operating Lease Liability Current7.63
Total Liabilities1,674.27
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock3,515.79
Retained Earnings / Accumulated Deficit-4,589.81
Accumulated Other Comprehensive Income27.28
Defined Benefit Plan and Other352.38
Other Equity27.28
Common Stockholder's Equity-1,047.50
Non-controlling interests & other0.87
Total Stockholder's Equity-1,046.63
Liabilities & Stockholder's Equity628.50
4 historic quarters locked

Sign in to unlock the full Immunitybio inc balance sheet history.

Sign In Create Free Account

About Immunitybio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001326110-26-000079

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.